Last reviewed · How we verify
rabeprazole and pantoprazole
rabeprazole and pantoprazole is a Small molecule drug developed by PriCara, Unit of Ortho-McNeil, Inc.. It is currently FDA-approved.
At a glance
| Generic name | rabeprazole and pantoprazole |
|---|---|
| Sponsor | PriCara, Unit of Ortho-McNeil, Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy (PHASE2)
- Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial (PHASE4)
- Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19
- Is Long-Term Proton Pump Inhibitor Use a Cause of Leaky Gut Syndrome (NA)
- Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding (PHASE4)
- Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults
- A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication (PHASE4)
- Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- rabeprazole and pantoprazole CI brief — competitive landscape report
- rabeprazole and pantoprazole updates RSS · CI watch RSS
- PriCara, Unit of Ortho-McNeil, Inc. portfolio CI
Frequently asked questions about rabeprazole and pantoprazole
What is rabeprazole and pantoprazole?
rabeprazole and pantoprazole is a Small molecule drug developed by PriCara, Unit of Ortho-McNeil, Inc..
Who makes rabeprazole and pantoprazole?
rabeprazole and pantoprazole is developed and marketed by PriCara, Unit of Ortho-McNeil, Inc. (see full PriCara, Unit of Ortho-McNeil, Inc. pipeline at /company/pricara-unit-of-ortho-mcneil-inc).
What development phase is rabeprazole and pantoprazole in?
rabeprazole and pantoprazole is FDA-approved (marketed).